Skip to content

Generation 100: How Exercise Affects Mortality and Morbidity in the Elderly: A Randomized Control Study

Generation 100: How Exercise Affects Mortality and Morbidity in the Elderly: A Randomized Control Study

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01666340
Acronym
GEN100
Enrollment
1567
Registered
2012-08-16
Start date
2012-08-21
Completion date
2026-06-30
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ageing

Keywords

Exercise, Elderly, Mortality, Morbidity, Prognosis, Longevity

Brief summary

Hypothesis: Exercise will reduce morbidity and mortality rates in an elderly population. The extent of reduction will be intensity dependent.

Detailed description

Literature lacks large controlled randomized studies that look at the effect of exercise training on morbidity and mortality. Generation 100 will be the first randomized, controlled clinical study where the primary objective is to study the effects of exercise training on morbidity and mortality in the elderly. Furthermore, the researchers will investigate whether there is a relationship between the exercise intensity and health benefits, with particular focus on major health problems in the elderly population. In addition to being a study, this is also an initiative to improve public health in all healthy individuals between 70-75 years of age in the Trondheim municipality. The participants will either be randomized to supervised exercise or follow current guidelines for physical activity on their own. Clinical examinations, as well as questionnaires, will be administered to all participants at baseline, after one year, after three years, and after five years. Additionally, participants will be followed-up by linking to relevant registers for up to 20 years. Also data will be collected with the purposes of (a) investigating genetic predisposition for fitness and cardiovascular diseases, and (b) identification of potential targets for therapies. The study seeks to determine if exercise training gives the seniors a longer active and healthy life.

Interventions

OTHERExercise intervention

Group asked to perform exercise at a given moderate intensity for a set time

Sponsors

Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
70 Years to 76 Years
Healthy volunteers
Yes

Inclusion criteria

* Born in 1936, 1937, 1938, 1939, 1940, 1941 or 1942 * Able to complete the exercise program (determined by the researchers).

Exclusion criteria

* Illness or disabilities that preclude exercise or hinder completion of the study * Uncontrolled hypertension * Symptomatic valvular, hypertrophic cardiomyopathy, unstable angina, pulmonary hypertension, heart failure and severe arrhythmia * Diagnosed dementia * Cancer that makes participation impossible or exercise contraindicated. Considered individually, in consultation with the attending physician. * Chronic communicable infectious diseases. * Test results indicating that study participation is unsafe * Participation in other studies conflicting with participation in Generation 100

Design outcomes

Primary

MeasureTime frameDescription
Mortality5 years follow upusing data from governmental registers

Secondary

MeasureTime frameDescription
General measurements1 year follow up, 3 years follow up, 5 years follow upresting blood pressure, resting fasting blood sample, resting heart rate, weight, height and waistline, body composition (muscle vs fat) questionnaires (activity, safety, monthly training diary) walking test, grip strength test, leg strength test, pulmonary function, physical activity level
Epigenetics1 year follow up, 3 years follow up, 5 years follow uptranscriptomics (messenger RNAs and microRNAs) and proteomics arrays, aimed at blood-borne factors induced by training.
Morbidity3 and 5 yearsLook at morbidity after 3 and 5 years follow up(i.e. cardiovascular disease, cancer, etc.) using medical records and link to the different health registers.
Mortality and Morbidity10 yearsLook at morbidity after 10 year follow-up

Other

MeasureTime frameDescription
Cognitive screening1 year follow up, 3 years follow up, 5 years follow utMini Mental Status (MMS)

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 20, 2026